Status:
COMPLETED
A Single-Center Pilot Study to Assess Macular Function
Lead Sponsor:
ORA, Inc.
Conditions:
Macular Degeneration
Eligibility:
All Genders
20-90 years
Brief Summary
This study seeks to evaluate a novel endpoint for future dry AMD clinical trials.
Eligibility Criteria
Inclusion
- Subjects in good health aged 20-29 or 60-90 years (normal cohorts)
- Subjects with early non-exudative age-related macular degeneration (AMD cohort)
Exclusion
- Enrollment in a investigational drug or device study and have used an investigational drug or device within 7 days of enrollment into this study
Key Trial Info
Start Date :
September 1 2010
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
October 1 2010
Estimated Enrollment :
24 Patients enrolled
Trial Details
Trial ID
NCT01204541
Start Date
September 1 2010
End Date
October 1 2010
Last Update
February 14 2012
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Andover, Massachusetts, United States, 01810